C O N M E D Corp CNMD

$47.23 +0.64 (1.37%)

Valuation

Market cap
1,319,974,000
Revenue TTM
$1,374,720,000
Net income TTM
$47,060,000
P/E (trailing)
9.65
P/E (forward)
9.98
Profit margin
3.42%
Debt to equity
0.80

Trading

Volume
509,899
Avg volume
367,874
Day's range
$46.25 – $47.79
Shares out
29,803,000
Stochastic %K
50%
Beta
0.94
Analysts
Hold
Price target
$47.00

Price

Company profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tiss...

Show more

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Industry
Medical Devices
Sector
Healthcare
Phone
727 392 6464
Website
https://www.conmed.com
Address
11311 Concept Boulevard, Largo, United States

Latest news

Stocktwits

filecrux Oct 29, 12:57 AM
$CNMD Does a higher $4.54 EPS floor make up for CONMED trimming the top of its 2026 sales range to $1,366M? 🏢 CONMED, a surgical device maker worth about $1.37B at $45.62 at 16:00 ET on October 28, 2026, reported Q3 2026 sales down 0.7% to $335.6M and adjusted EPS down 3.2% to $1.04 🚀 It lifted adjusted EPS guidance to $4.54–$4.61 from $4.48–$4.60, so at $45.62 at 16:00 ET on October 28, 2026 the stock trades at about 10 times the new midpoint 📈 On the other side, the CEO said organic growth met plan and adjusted EPS beat it, and Q3 adjusted EBITDA rose to $67.9M from $65.6M while GAAP diluted EPS jumped to $0.66 from $0.09 📅 Next: Management discusses Q3 on its 4:30 p.m. ET call today, and the question is whether US sales, down 11.0% as reported but up only 0.8% organically excluding exited GI products, can pick up, and why the sales ceiling slipped Source: CONMED Q3 release, SEC 8-K, Oct 28
0 replies
Estimize Oct 28, 11:30 PM
$CNMD reported 1.04 EPS and 335.56 revenue for Q3. http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_content=CNMD&utm
0 replies
EarningsInsider Oct 28, 9:32 PM
https://www.marketbeat.com/earnings/reports/2026-10-28-conmed-co-stock/ $CNMD CONMED Earnings Transcript
0 replies
shoc24 Oct 28, 8:50 PM
$CNMD reported earnings after the close: EPS of $1.04 vs. $1.00 estimated, a beat of 4.0%. I used Stock Meadow to review the results. What do you think?
0 replies
StocktwitsEarnings Oct 28, 8:14 PM
$CNMD Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.04 down -3.70% YoY • Reported revenue of $335.56M down -0.70% YoY • CONMED expects to repurchase approximately $62M in 2026 under its authorized share repurchase program; no quantified revenue, margin, or earnings outlook is provided in this filing.
0 replies
shoc24 Oct 28, 4:31 PM
$CNMD reports earnings today after the close. I’m bullish heading into the report: CNMD has beaten EPS estimates in 8 of its last 8 reports, according to Stock Meadow. What are you watching for?
0 replies
shoc24 Oct 27, 9:54 PM
$CNMD reports earnings tomorrow after the close. I’m bullish heading into the report: CNMD has beaten EPS estimates in 8 of its last 8 reports, according to Stock Meadow. Analysts expect EPS of $1.00. What are you watching for?
0 replies
Estimize Oct 26, 3:00 PM
Wall St is expecting 1.00 EPS for $CNMD Q3 [Reporting 10/28 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 replies